Obesity and microalbuminuria. Revision article
Abstract
The obesity is the the 21st century epidemic according to the World Health Organization. It is the most common form of malnutrition and It has gone reaching ascending proportions as much in developed countries as developing countries, the prevalence has tripled in the last three decades. For 2020 this prevalence will reach 35% in Europe and 45% in America, and even in Asia could reach 20%. Actuality, there is a big concern about the consequences. It affirms that more than the third part of the queries of consultation in Pediatric Endocrinology corresponds to this cause. The obesity deleterious effects are related to the risk of suffering diseases like diabetes, Systemic arterial hypertension and Cardiovascular Diseases, between others. The obesity and the physical activity are two determinants of the metabolic syndrome. The first sign of kidney injury is the microalbuminuria, which is associated with obesity, arterial hypertension, dyslipidemia, glucose intolerance or diabetes mellitus. It was considered positive microalbuminuria to the values comprised between 0,02 and 0,2 g/L; Microalbuminuria is an indicator of cardiovascular risk and endothelium dysfunction by which has to be indicated for early detection of the obesity complications, using it as a strategy to diminish Chronic non-communicable diseasesDownloads
References
World Health Orgaization. Obesity, preventing and managing the global pandemic. Geneva: WHO; 1997.
González Sánchez R, Llapur Milián R, Olivares Rubio D. Caracterización de la obesidad en los adolescentes. Rev Cubana Pediatr. 2009; 81(2):40-6.
Cabrera Rode E, Cálix Iglesias WD, Stusser Iglesias BI, Parlá Sardiñas J, Álvarez Álvarez A, Olano Justiniani R, et al. Relación de la resistencia a la insulina con el riesgo cardiovascular, según diferentes tablas y factores de riesgo cardiovascular en sujetos sobrepesos y obesos. Rev Cubana Endocrinol [Internet]. 2013 [citado 9 Feb 2014]; 24(2): 136-152. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532013000200004&lng=es.
Medina Alí F, Medina Arango R, Ruiz de Villa Martínez Y, Gutiérrez Macías A. Caracterización clínica y bioquímica de la obesidad en niños y adolescentes. Rev Cienc Holguín [Internet]. 2010 [citado 9 Feb 2014]; 16(4): [aprox. 8 p.]. Disponible en: http://www.ciencias.holguin.cu/index.php/cienciasholguin/article/view/569
González Sánchez R, Llapur Milián R, Díaz Sánchez ME, Moreno López V, Pavón Hernández M. Hipertensión arterial y obesidad en escolares de cinco a once años de edad. Rev Cubana Pediatr [Internet]. 2013 [citado 9 Feb 2014]; 85(4): 418-427. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312013000400002&lng=es
Lee Jones K. Rol de la obesidad frente al diagnóstico de diabetes infantojuvenil. Pediatrics. 2008; 121; 361-368.
Piñeiro Lamas K, Callejas de la Peña L, Pacheco Torres MC, Duarte MC, Valdés Alonso R. Microalbuminuria en adolescentes obesos. Rev Cubana Pediatr [Internet]. 2009 [citado 9 Feb 2014]; 81(2): [aprox. 8 p.]. Disponible en: http://www.bvs.sld.cu/revistas/ped/vol81_2_09/ped06209.htm
Roger Dobson A. WHO should take the lead in combating obesity. Br Med J. 2005; 330:1168-70.
Jiménez JM. Estudio transversal de crecimiento y desarrollo en niños y jóvenes habaneros de 9 a 19, Ciudad de La Habana, 1998 [CD-ROM]. México: Museo Antropológico Montané; 2003.
Cuba. Unión de Jóvenes Comunistas; Ministerio de Salud Pública. Estudio Integral de la Población Infantil en Menores de 15 años, La Habana: MINSAP; 2005.
Jiménez Acosta SM, Rodríguez Suárez A. Evolución del sobrepeso en preescolares cubanos en un período de diez años. Rev Cubana Pediatr [Internet]. 2013 [citado 9 Feb 2014]; 85(4): 428-438. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312013000400003&lng=es
Rivero González M, Cabrera Panizo R, Luis Álvarez M, Pantoja Pereda O. Alteraciones metabólicas en pacientes obesos y su asociación con la acantosis nigricans. Rev Cubana Pediatr [Internet]. 2012 [citado 9 Feb 2014]; 84(1): 1-10. Disponible en: http://scielo.sld.cu/scielo.php?pid=S0034-75312012000100001&script=sci_arttext
Savino A, Pelliccia P, Chiarelli F, Mohn A. Obesity-related renal injury in childhood. Horm Res Paediatr. 2010; 73:303-11.
Santiago Martínez Y, Miguel Soca PE, Ricardo Santiago A, Marrero Hidalgo MM, Peña Pérez I. Caracterización de niños y adolescentes obesos con síndrome metabólico. Rev Cubana Pediatr [Internet]. 2012 84(1): 11-21. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312012000100002&lng=es
Esquivel M. Valores cubanos de índice de masa corporal en niños de 0 a 19 años. Rev Cubana Pediatr. 1991; 63:180-90.
Mokhad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes and obesity-related health risk factors. JAMA. 2003; 289: 76-79.
Pérez Samper LA, Santana Sardiñas S, Pérez Cruz N, Expósito Palmero O. Caracterización de la obesidad exógena en un grupo de pacientes atendidos en consulta de endocrinología pediátrica. MediCiego [Internet]. 2011 [citado 13 Mar 2013]; 17(Supl. 2): [aprox. 8 p.]. Disponible en: http://www.bvs.sld.cu/revistas/mciego/vol17_supl2_%202011/pdf/T11.pdf
Stray-Pedersen M, Helsing RM, Gibbons L, Cormick G, Holmen TL, Vik T, et al. Weight status and hypertension among adolescent girls in Argentina and Norway: data from the ENNyS and HUNT studies. BMC Public Health. 2009; 9:398.
Ke L, Brock KE, Cant RV, Li Y, Morrell SL. The relationship between obesity and blood pressure differs by ethnicity in Sydney school children. Am J Hypertens. 2009; 22(1):52-8.
Gimeno Orna JA, Lou Arnal LM, Molinero Herguedas E, Boned Juliani B, Portilla-Córdoba D. Síndrome metabólico como marcador de riesgo cardiovascular en pacientes con diabetes tipo 2. Rev Esp Cardiol. 2004; 57:507-13.
Julio Mayorga A, Vergara MÁ, Guillén IE. Prevalencia de microalbuminuria en pacientes obesos y con sobrepeso Rev Endocrinol Nutr. 2008; 16(4): 158-164.
Gimeno Orna JA, Molinero Herguedas E, Lou Arnal LM, Boned Juliani B, Labrador Fuster T, Guiu Campos M. La microalbuminuria explica el incremento de riesgo vascular en pacientes con diabetes y síndrome metabólico. Rev Esp Cardiol. 2007; 60:1202-5.
Pascual J, Liaño F. Valor predictivo de la microalbuminuria. Med Clin (Barc). 2000; 114(19): 732-4.
Mundet Tuduri X, Tomás Santos P, Gimbert Ràfols R . ¿Cómo valorar la microalbuminuria? Atenc Prim. 1996; 17(3):175-6.
Licea Puig ME, Singh Linares O, Gárciga Cardoso F. Asociación de la microalbuminuria con la disfunción ventricular izquierda en personas normotensas con diabetes mellitus tipo 1. Rev Cubana Endocrinol [Internet]. 2009 [citado 13 Mar 2013]; 20(1): [aprox. 8 p.]. Disponible en: http://scielo.sld.cu/scielo.php?pid=S1561-29532009000100004&script=sci_arttext
González Sánchez R, Llapur Milián R, Rubio Olivares D. Caracterización de la obesidad en los adolescentes. Rev Cubana Pediatr [Internet]. 2009 [citado 13 Mar 2013]; 81(2): [aprox. 8 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312009000200003&lng=es&nrm=iso&tlng=es
Downloads
Published
How to Cite
Issue
Section
License
Those authors who have publications with this journal accept the following terms of the License CC Attribution-NonCommercial 4.0 International (CC BY-NC 4.0):
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes .
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
The journal is not responsible for the opinions and concepts expressed in the works, which are the exclusive responsibility of the authors. The Editor, with the assistance of the Editorial Committee, reserves the right to suggest or request advisable or necessary modifications. Original scientific works are accepted for publication, as are the results of research of interest that have not been published or sent to another journal for the same purpose.
The mention of trademarks of specific equipment, instruments or materials is for identification purposes, and there is no promotional commitment in relation to them, neither by the authors nor by the editor.
